NR1H4 and metabolic dysfunction-associated steatotic liver disease: Dysregulation of bile acid metabolism and FXR signaling in the gut-to-liver axis contributes to metabolic diseases including obesity, diabetes, and non-alcoholic fatty liver disease (NAFLD) (8).